- /
- Supported exchanges
- / US
- / DCTH.NASDAQ
Delcath Systems Inc (DCTH NASDAQ) stock market data APIs
Delcath Systems Inc Financial Data Overview
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Delcath Systems Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Delcath Systems Inc data using free add-ons & libraries
Get Delcath Systems Inc Fundamental Data
Delcath Systems Inc Fundamental data includes:
- Net Revenue: 95 418 K
- EBITDA: -1 455 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Delcath Systems Inc News
New
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
Teleflex TFX shares rallied 4.3% in the last trading session to close at $127.38. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session....
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
Veracyte VCYT shares ended the last trading session 10.8% higher at $48.54. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compar...
Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Delcath Systems, Inc. (DCTH) is a stock that can certainly grab t...
Delcath’s (DCTH) Liver Cancer Device Keeps Growing, But At A Cost
On August 6, Delcath Systems (NASDAQ:DCTH) reported second-quarter results that showed the company selling more of its liver cancer treatment than ever, even as the cost of running the business climbe...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.